Kynurenine inhibits chondrocyte proliferation and is increased in synovial fluid of patients with septic arthritis

✍ Scribed by Tim T. Lögters; Maurice D. Laryea; Marcus Jäger; Michael Schädel-Höpfner; Joachim Windolf; Sascha Flohé; Jens Altrichter; Martin Scholz; Adnana N. Paunel-Görgülü

• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 285 KB
• Volume: 28
• Category: Article
• ISSN: 0736-0266
• DOI: 10.1002/jor.21158

✦ Synopsis

Abstract

Kynurenine, the major degradation product of tryptophan has been shown to directly damage various tissues. Its potential contribution to septic arthritis is unknown. In this study, we analyzed the putative diagnostic value of kynurenine for bacterial joint infection and its potential harmful effects on cartilage. In a prospective study 41 patients with a joint effusion who had undergone arthrocentesis were included. Tryptophan and kynurenine levels from synovial fluid were quantified by HPLC. Diagnostic value of kynurenine was evaluated and its effects on the proliferation of the chondrocyte cell line ATDC5 were determined. Synovial fluid kynurenine values from patients with septic arthritis (4.1 ± 0.8 µmol/L, n = 9) were significantly increased compared to patients with non‐infectious inflammatory arthropathy (1.8 ± 0.2 µmol/L, n = 17) or osteoarthritis (1.2 ± 0.1 µmol/L, n = 15, p < 0.01). At a cut‐off value of 2.28 µmol/L kynurenine had a sensitivity of 0.89 and a specificity of 0.87. Further, kynurenine inhibited chondrocyte (ATDC5) cell proliferation in a dose‐dependent manner. Septic arthritis is associated with significantly increased values of synovial kynurenine. Furthermore kynurenine inhibits proliferation of chondrocytes, which strongly suggests a pathophysiological effect of kynurenine on cartilage in inflammatory arthropathies. © 2010 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 28:1490–1496, 2010